Nuveen
MESO icon

Nuveen’s Mesoblast MESO Stock Holding History

Nuveen’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$59 Buy
+4
New +$63 ﹤0.01% 5052

Other funds holding MESO

Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
BCS Private Wealth Management
BCS Private Wealth Management Rumson, New Jersey $366M AUM 18.54% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Visionary Wealth Advisors
Visionary Wealth Advisors O'fallon, Illinois $2.55B AUM 17.5% 1-Year Est. Return

Nuveen's MESO Position: Q3 2026 in Review

Nuveen opened a new position in Mesoblast (MESO) in Q3 2026: 4 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #5052 among its holdings.

33 funds tracked by Wall St. Rank hold MESO as of Q3 2026.

  • Nuveen held 4 shares of Mesoblast worth $59 as of Q3 2026.
  • Mesoblast was a new Nuveen position in Q3 2026.
  • Mesoblast made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #5052 holding.
  • 33 funds tracked by Wall St. Rank held Mesoblast as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.